Literature DB >> 16798095

Molecular dynamics study on the ligand recognition by tandem SH3 domains of p47phox, regulating NADPH oxidase activity.

Yoko Watanabe1, Hideyuki Tsuboi, Michihisa Koyama, Momoji Kubo, Carlos A Del Carpio, Ewa Broclawik, Eiichiro Ichiishi, Masahiro Kohno, Akira Miyamoto.   

Abstract

The phagocyte NADPH oxidase complex plays a crucial role in host defense against microbial infection through the production of superoxides. Chronic granulomatous disease (CGD) is an inherited immune deficiency caused by the absence of certain components of the NADPH oxidase. Key to the activation of the NADPH oxidase is the cytoplasmic subunit p47phox, which includes the tandem SH3 domains (N-SH3 and C-SH3). In active phagocytes, p47phox forms a stable complex with the cytoplasmic region of membrane subunit p22phox that forms a left-handed polyproline type-II (PPII) helix conformation. In this report, we have analyzed the conformational changes of p47phox-p22phox complexes of wild-type and three mutants, which have been detected in CGD patients, using molecular dynamics simulations. We have found that in the wild-type, two basal planes of PPII prism in cytoplasmic region of p22phox interacted with N-SH3 and C-SH3. In contrast, in the modeled mutants, the residue at the ape of PPII helix, which interacts simultaneously with both of the tandem SH3 domains in the wild-type, moved toward C-SH3. Furthermore, interaction energies of the cytoplasmic region of p22phox with C-SH3 tend to decrease in these mutants. All these findings led us to conclude that interactions between N-SH3 of p47phox and PPII helix, which is formed by cytoplasmic region of p22phox, may play a significant role in the activation of the NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798095     DOI: 10.1016/j.compbiolchem.2006.04.004

Source DB:  PubMed          Journal:  Comput Biol Chem        ISSN: 1476-9271            Impact factor:   2.877


  4 in total

Review 1.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

2.  In silico phosphorylation of the autoinhibited form of p47(phox): insights into the mechanism of activation.

Authors:  Flavia Autore; Bruno Pagano; Arianna Fornili; Katrin Rittinger; Franca Fraternali
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

3.  Assignment of PolyProline II conformation and analysis of sequence--structure relationship.

Authors:  Yohann Mansiaux; Agnel Praveen Joseph; Jean-Christophe Gelly; Alexandre G de Brevern
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

4.  Molecular insights of p47phox phosphorylation dynamics in the regulation of NADPH oxidase activation and superoxide production.

Authors:  Daniel N Meijles; Lampson M Fan; Brendan J Howlin; Jian-Mei Li
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.